208 related articles for article (PubMed ID: 27547861)
21. Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.
Miller JD; Bonafede MM; Herschorn SD; Pohlman SK; Troeger KA; Fajardo LL
J Am Coll Radiol; 2017 Apr; 14(4):467-474.e5. PubMed ID: 28139412
[TBL] [Abstract][Full Text] [Related]
22. Increased Cancer Detection Rate and Variations in the Recall Rate Resulting from Implementation of 3D Digital Breast Tomosynthesis into a Population-based Screening Program.
Sharpe RE; Venkataraman S; Phillips J; Dialani V; Fein-Zachary VJ; Prakash S; Slanetz PJ; Mehta TS
Radiology; 2016 Mar; 278(3):698-706. PubMed ID: 26458206
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of breast cancer screening in women on dialysis.
Wong G; Howard K; Chapman JR; Craig JC
Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
[TBL] [Abstract][Full Text] [Related]
25. Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.
Tina Shih YC; Dong W; Xu Y; Shen Y
Value Health; 2019 Feb; 22(2):185-193. PubMed ID: 30711063
[TBL] [Abstract][Full Text] [Related]
26. Incremental effect from integrating 3D-mammography (tomosynthesis) with 2D-mammography: Increased breast cancer detection evident for screening centres in a population-based trial.
Caumo F; Bernardi D; Ciatto S; Macaskill P; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Houssami N
Breast; 2014 Feb; 23(1):76-80. PubMed ID: 24316152
[TBL] [Abstract][Full Text] [Related]
27. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.
Yeh JM; Lowry KP; Schechter CB; Diller LR; Alagoz O; Armstrong GT; Hampton JM; Leisenring W; Liu Q; Mandelblatt JS; Miglioretti DL; Moskowitz CS; Oeffinger KC; Trentham-Dietz A; Stout NK
Ann Intern Med; 2020 Sep; 173(5):331-341. PubMed ID: 32628531
[TBL] [Abstract][Full Text] [Related]
28. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of digital mammography breast cancer screening.
Tosteson AN; Stout NK; Fryback DG; Acharyya S; Herman BA; Hannah LG; Pisano ED;
Ann Intern Med; 2008 Jan; 148(1):1-10. PubMed ID: 18166758
[TBL] [Abstract][Full Text] [Related]
31. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
[TBL] [Abstract][Full Text] [Related]
32. Retrospective cost-effectiveness analysis of screening mammography.
Stout NK; Rosenberg MA; Trentham-Dietz A; Smith MA; Robinson SM; Fryback DG
J Natl Cancer Inst; 2006 Jun; 98(11):774-82. PubMed ID: 16757702
[TBL] [Abstract][Full Text] [Related]
33. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
34. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images.
Skaane P; Bandos AI; Eben EB; Jebsen IN; Krager M; Haakenaasen U; Ekseth U; Izadi M; Hofvind S; Gullien R
Radiology; 2014 Jun; 271(3):655-63. PubMed ID: 24484063
[TBL] [Abstract][Full Text] [Related]
35. Comparative Benefit-to-Radiation Risk Ratio of Molecular Breast Imaging, Two-Dimensional Full-Field Digital Mammography with and without Tomosynthesis, and Synthetic Mammography with Tomosynthesis.
Brown M; Covington MF
Radiol Imaging Cancer; 2019 Sep; 1(1):e190005. PubMed ID: 33778669
[TBL] [Abstract][Full Text] [Related]
36. Evidence on Synthesized Two-dimensional Mammography Versus Digital Mammography When Using Tomosynthesis (Three-dimensional Mammography) for Population Breast Cancer Screening.
Houssami N
Clin Breast Cancer; 2018 Aug; 18(4):255-260.e1. PubMed ID: 29066138
[TBL] [Abstract][Full Text] [Related]
37. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
39. Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods.
de Koning HJ; Heijnsdijk EA
J Med Screen; 2015 Dec; 22(4):201-6. PubMed ID: 26018779
[TBL] [Abstract][Full Text] [Related]
40. Digital Breast Tomosynthesis: Cost-Effectiveness of Using Private and Medicare Insurance in Community-Based Health Care Facilities.
Hunter SA; Morris C; Nelson K; Snyder BJ; Poulton TB
AJR Am J Roentgenol; 2017 May; 208(5):1171-1175. PubMed ID: 28177646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
